CASI Pharmaceuticals Holdings Inc

CASI Pharmaceuticals Holdings Inc. navigates market challenges and opportunities in the healthcare sector, positioning itself for future growth through innovation and strategic partnerships.

CASI Pharmaceuticals Holdings Inc is a healthcare company focused on developing and commercializing innovative therapeutics, with a strong global presence and a robust pipeline of potential treatments.

CASI Pharmaceuticals Holdings Inc. has announced a major divestiture of its Chinese assets to Kaixin Pharmaceuticals Inc. for approximately $20 million, aiming to streamline operations and focus on core competencies.